Serum autotaxin levels are associated with Graves’ disease-Reference-Cited by-同舟云学术

Serum autotaxin levels are associated with Graves’ disease

Published:2019 Issue:5 Volume:66 Page:409-422
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Nojiri Takahiro¹²,Kurano Makoto¹³,Araki Osamu⁴,Nakawatari Kazuki¹,Nishikawa Masako³,Shimamoto Satoshi⁵,Igarashi Koji⁵,Kano Kuniyuki⁶,Aoki Junken⁶,Kihara Shinji²,Murakami Masami⁶,Yatomi Yutaka¹³

Affiliation:

1. Department of Clinical Laboratory, The University of Tokyo Hospital, Tokyo, Japan

2. Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan

3. Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

4. Department of Clinical Laboratory Medicine, Gunma University Graduate School of Medicine, Gunma, Japan

5. Bioscience Division, TOSOH Corporation, Kanagawa, Japan

6. Laboratory of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Miyagi, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/66/5/66_EJ18-0451/_pdf

Reference44 articles.

1. 1 Smith TJ, Hegedus L (2016) Graves’ Disease. N Engl J Med 375: 1552–1565.

2. 2 Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, et al. (2002) Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158: 227–233.

3. 3 Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, et al. (2007) Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J Clin Gastroenterol 41: 616–623.

4. 4 Nakagawa H, Ikeda H, Nakamura K, Ohkawa R, Masuzaki R, et al. (2011) Autotaxin as a novel serum marker of liver fibrosis. Clin Chim Acta 412: 1201–1206.

5. 5 Ikeda H, Kobayashi M, Kumada H, Enooku K, Koike K, et al. (2018) Performance of autotaxin as a serum marker for liver fibrosis. Ann Clin Biochem 55: 469–477.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum autotaxin level: a promising diagnostic biomarker in differentiating Graves’ disease and thyroiditis;Journal of Pharmacy and Pharmacology;2024-07-18

2. Lysophospholipids and their producing enzymes: Their pathological roles and potential as pathological biomarkers;Pharmacology & Therapeutics;2023-06

3. Regulation of CD8 T‐cell signaling, metabolism, and cytotoxic activity by extracellular lysophosphatidic acid;Immunological Reviews;2023-04-25

4. Decrease in serum levels of autotaxin in COVID-19 patients;Annals of Medicine;2022-11-11

5. Decreased serum interleukin‐41/Metrnl levels in patients with Graves' disease;Journal of Clinical Laboratory Analysis;2022-08-29